Search

H1N1 influenca virus particle
© NIAID

Known medicines: New role in combating infections?

Looking for an effective treatment of serious influenza infections, researchers of the Paul-Ehrlich-Institut have used bioinformatics to screen licensed medicines for their potential efficacy against

Coalition for Epidemic Preparedness Innovations (CEPI)

The global community wants to be better prepared for serious infectious disease epidemics than before. For this purpose, the…

BioNTech

In collaboration with BioNTech and the biopharmaceutical research institute Translational Oncology at the University of Mainz…

Tuberculosis bacteria
© CDC/James Archer

Tuberculosis: The search for new drugs continues

Every year on 24 March, we commemorate Robert Koch’s discovery of the tubercle bacillus. Almost 140 years later, tuberculosis is still the leading infectious disease with the most number of deaths

Developing Medication

Developing a new medication usually takes more than ten years. Out of the several thousand substances investigated in basic and pre-clinical research, only one or two candidates are approved by

Translation

What is translation? Basic scientific and medical research are the foundation for gaining knowledge and driving progress. The scientists at the DZIF pursue the aim of strategically transferring the
München

International Clinical Trials Unit

New HIV infections occur mostly outside of Europe. That is why the DZIF has set up its own task force to coordinate clinical trials on location (mainly in Africa). The "International Clinical Trials Unit" gives DZIF member institutions access to large existing cohorts and biobanks that they can use ...

Hannover - Braunschweig | München | Tübingen

Center for Gastrointestinal Clinical Trials (CEGICLIN)

CEGICLIN is a virtual center for gastrointestinal clinical trials. Study nurses from this center are available to the three DZIF Partner Sites involved in this area of research. The Center also collaborates closely with the DZIF’s clinical trial units and regional clinical trial centers. This ...

Hamburg - Lübeck - Borstel - Riems

Clinical management, epidemiology and immunology of newly emerging infections

This research group, led by Professor Marylyn Addo, initiates and coordinates translational research in the field of emerging infections with a particular focus on Ebola, MERS, Lassa and Crimean-Congo haemorrhagic fever. Immunology studies, vaccine development, testing of novel anti-infectives and ...